| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/03/2004 | US6685962 Enclosed in insoluble membranes |
| 02/03/2004 | US6685959 Pharmaceutical compositions comprising 2-isoxazoles-8-aminotetralin derivatives |
| 02/03/2004 | US6685954 For application to skin |
| 02/03/2004 | US6685934 Neurodegenerative diseases. |
| 02/03/2004 | US6685930 When binding molecules reach maximum concentration in tumor a liposome conjugated with antibodies is administered to clear them from the blood; single chain vh-vl binding molecules conjugated with peptide linker, solid tissue antigen binder |
| 02/03/2004 | US6685928 Therapeutic compositions and methods |
| 02/03/2004 | US6685924 Conjugate, its preparation and use |
| 02/03/2004 | US6685917 Treatment of mucositis |
| 02/03/2004 | US6685730 Optically-absorbing nanoparticles for enhanced tissue repair |
| 02/03/2004 | CA2300806C Dexamethasone gel |
| 02/03/2004 | CA2182244C Camptothecin derivatives |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 02/03/2004 | CA2079444C Binding of recognizing substances to liposomes |
| 01/31/2004 | CA2436469A1 Composition for heart disease, method to prepare same and uses thereof |
| 01/31/2004 | CA2432676A1 Development of an in vivo functional assay for proteases |
| 01/31/2004 | CA2425568A1 Herbal pharmaceutical composition for treatment of hiv/aids patients |
| 01/29/2004 | WO2004009774A2 Protein conjugates with a water-soluble biocompatible, biogradable polymer |
| 01/29/2004 | WO2004009672A1 Polyalkylene glycols, derivatives and conjugates thereof in particulate form |
| 01/29/2004 | WO2004009666A2 Dendrimers as molecular translocators |
| 01/29/2004 | WO2004009665A2 Dendrimers as molecular translocators |
| 01/29/2004 | WO2004009664A2 Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from |
| 01/29/2004 | WO2004009627A1 Pegylated erythropoietic compounds |
| 01/29/2004 | WO2004009517A2 Method for incorporating anionic molecules into a substrate for increasing dispersibility of anionic molecules |
| 01/29/2004 | WO2004009136A2 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
| 01/29/2004 | WO2004009135A2 Conjugates of biocompatible polymers with nuclide activation therapy reagents |
| 01/29/2004 | WO2004009127A1 Localized delivery system for phenstatin using n-isopropylacrylamide |
| 01/29/2004 | WO2004009126A1 Targeted agents for nerve regeneration |
| 01/29/2004 | WO2004009125A2 Bisacyloxypropylcysteine conjugates and the use thereof |
| 01/29/2004 | WO2004009124A2 Ghrelin-carrier conjugates |
| 01/29/2004 | WO2004009123A2 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 01/29/2004 | WO2004009122A1 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |
| 01/29/2004 | WO2004009120A1 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 01/29/2004 | WO2004009116A2 Hapten-carrier conjugates comprising virus like particles and uses thereof |
| 01/29/2004 | WO2004009112A1 Use of urease for inhibiting cancer cell growth |
| 01/29/2004 | WO2004009108A1 Antipyrotic and method of manufacturing the same |
| 01/29/2004 | WO2004009089A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/29/2004 | WO2004009082A1 Oxime conjugates and methods for their formation and use |
| 01/29/2004 | WO2004009080A1 Levamisole, Avermectins or similar in pyrrolidone solvent |
| 01/29/2004 | WO2004009077A1 TASTE-MASKED LIQUID PHARMACEUTICAL COMPOSITION COMPRISING A COMPLEX OF A HISTAMINE h2-RECEPTOR ANTAGONIST AND ALGINATE |
| 01/29/2004 | WO2004009076A1 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof |
| 01/29/2004 | WO2004009075A1 Composition for solubilization of paclitaxel and preparation method thereof |
| 01/29/2004 | WO2004009064A1 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 01/29/2004 | WO2004009063A1 TOPICAL ANTIINFLAMMATORY PREPARATIONS OF η-TERPINENE |
| 01/29/2004 | WO2004009061A2 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 01/29/2004 | WO2004009058A1 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| 01/29/2004 | WO2004009056A1 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent |
| 01/29/2004 | WO2004009035A2 Compositions and products containing enantiomeric equol, and methods for their making |
| 01/29/2004 | WO2004009019A2 Method for incorporating cationic molecules into a substrate for increasing dispersibility of cationic molecules |
| 01/29/2004 | WO2003094827A3 Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles |
| 01/29/2004 | WO2003070887A3 RNA INTERFERENCE MEDIATED INHIBITION OF POLYCOMB GROUP PROTEIN EZH2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/29/2004 | WO2003065980A3 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 01/29/2004 | WO2003057153A3 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 01/29/2004 | WO2003047631A3 Clasp-pna-conjugate for the specific transport of nucleic acids which are thermally active |
| 01/29/2004 | WO2003028654A3 Storage-stable human fibrinogen solutions |
| 01/29/2004 | WO2003020324A3 Methods for sterilizing preparations of digestive enzymes |
| 01/29/2004 | WO2003017947A3 Spontaneous emulsions containing cyclosporine |
| 01/29/2004 | WO2002086134B1 Buffer solution for electroporation and a method comprising the use of the same |
| 01/29/2004 | WO2002077036A3 Recombinant production of polyanionic polymers, and uses thereof |
| 01/29/2004 | WO2002064014A9 Endomural therapy |
| 01/29/2004 | WO2002055021A9 Glycopolymers and free radical polymerization methods |
| 01/29/2004 | US20040019232 Analogs of phosphonate and bisphosphonate compounds based on bone resorption suppressors (alendronic acid), viricides (cidofovir) and antineoplastic agents (bemcitabine); nontoxic; bioavailability; side effects reduction |
| 01/29/2004 | US20040019211 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 01/29/2004 | US20040019184 Remedies for ischemic disease |
| 01/29/2004 | US20040019122 Solid dispersion composition |
| 01/29/2004 | US20040019075 New formulation for the parenteral application of crobenetine |
| 01/29/2004 | US20040019074 Mixtures of fatty esters, lipophilic excipients and nonionic surfactants, used as solubilizers for drugs selected from rapamycin, tacrolimus, deoxyspergualin, mycophenolate-mofetil, nifedipine, nimodipine, etoposide or ibuprofen |
| 01/29/2004 | US20040019073 Mixtures of di-2-thienylglycolates, water, buffers, preservatives and stabilizer agents, administered for prophylaxis of respiratory system disorders such as asthma or chronic obstructive pulmonary disease |
| 01/29/2004 | US20040019014 Washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins, dissolving the starch in aqueous medium, molecular weight reduction by shearing |
| 01/29/2004 | US20040019013 Formulation for the parenteral application of a sodium channel blocker |
| 01/29/2004 | US20040019012 A therapeutic drug suitable for topical administration to an eye, containing an antibiotic for gram-positive bacterial infection, a cyclodextrin compound to maintain drug in solution and cetylpyridium chloride |
| 01/29/2004 | US20040019011 Treatment of conitions and disease |
| 01/29/2004 | US20040019010 Carrageenan viscoelastics for ocular surgery |
| 01/29/2004 | US20040019007 Intravascular delivery of non-viral nucleic acid |
| 01/29/2004 | US20040019001 Modulation gene expression |
| 01/29/2004 | US20040018992 Pharmaceutical compositions for sparingly soluble therapeutic agents |
| 01/29/2004 | US20040018974 Multivalent constructs for therapeutic and diagnostic applications |
| 01/29/2004 | US20040018962 Drug delivery vehicles |
| 01/29/2004 | US20040018961 Forming micelles in aqueous solution; adjustment pH; stabilization |
| 01/29/2004 | US20040018960 Antitumor agents; autoimmune diseases; antiarthritic agents; restenosis |
| 01/29/2004 | US20040018956 Aporphine esters and their use in therapy |
| 01/29/2004 | US20040018571 PSCA: prostate stem cell antigen and uses thereof |
| 01/29/2004 | US20040018557 High speed elimination of immunoglobulins from human body |
| 01/29/2004 | US20040018327 Delayed release dosage forms |
| 01/29/2004 | US20040018252 Which destroy, inhibit or therapeutically significantly limit microbial growth within said preparations or medications |
| 01/29/2004 | US20040018251 Petasite extract is recovered from plant of the genus Petasites; effective in treating gastrointestinal diseases, asthmas, pollinosis, dysmenorrhea, eczemas, migraines, psoriasis and high blood pressure |
| 01/29/2004 | US20040018243 Modulation of release from dry powder formulations |
| 01/29/2004 | US20040018242 Nanoparticulate nystatin formulations |
| 01/29/2004 | US20040018241 Bioadhesive compositions and methods for topical administration of active agents |
| 01/29/2004 | US20040018239 Pharmaceutical preparation containing copolyvidone |
| 01/29/2004 | US20040018238 Biodegradable vehicles and delivery systems of biolgically active substances |
| 01/29/2004 | US20040018237 Topical drug delivery using phosphatidylcholine |
| 01/29/2004 | US20040018233 An expectorant drug delivery dosage forms comprises a sustained release portion and an immediate release portion; relieving from bronchial mucus accumulation |
| 01/29/2004 | US20040018232 Drugs comprising titanium dioxide pigments, titanium dioxide and/or iron oxide coated on inorganic substrates; use as food color |
| 01/29/2004 | US20040018225 Triacylglycerols of enriched CLA content |
| 01/29/2004 | US20040018223 Gelatinous food elastomer compositions and articles |
| 01/29/2004 | US20040018222 Amphiphilic polysaccharide has hydrophilic-lipophilic properties, dispersing both in water and in oil, no thickening properties; use in cosmetic or dermatology |
| 01/29/2004 | US20040018203 Connector molecule attaching a targeting molecule to an effector molecule is conjugated to polyethylene glycol (peg) molecules |
| 01/29/2004 | US20040018200 >/= 15 mg/ml of an antibody, or a fragment that immunospecifically binds to a respiratory syncytial virus antigen and histidine in an aqueous carrier |
| 01/29/2004 | US20040018196 Proteins and nucleic acids encoding same |
| 01/29/2004 | US20040018194 Administering proteins that bind to CD30, or compete with monoclonal antibodies AC10 or HeFi-1 for binding to CD30, and exert a cytostatic or cytotoxic effect on Hodgkin's disease cells in the absence of effector cells or complement |